Variant report
Variant | esv3412636 |
---|---|
Chromosome Location | chr9:17997677-17998253 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185644373 | chr9:17997677-17997678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs553056634 | chr9:17997714-17997715 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574693333 | chr9:17997727-17997728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542011493 | chr9:17997728-17997729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557739849 | chr9:17997758-17997759 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563621357 | chr9:17997769-17997770 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537449790 | chr9:17997774-17997775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs62553114 | chr9:17997775-17997776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs79504993 | chr9:17997778-17997779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs116951187 | chr9:17997790-17997791 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576091137 | chr9:17997819-17997820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532514206 | chr9:17997827-17997828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541132649 | chr9:17997831-17997832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559382484 | chr9:17997832-17997833 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7867406 | chr9:17997898-17997899 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs60504802 | chr9:17997958-17997959 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs149470209 | chr9:17997971-17997972 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs531096068 | chr9:17997980-17997981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs552192621 | chr9:17998001-17998002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368371040 | chr9:17998024-17998025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370576081 | chr9:17998055-17998056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs111640202 | chr9:17998076-17998077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543627448 | chr9:17998089-17998090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7856954 | chr9:17998102-17998103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs7043577 | chr9:17998105-17998106 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs568133761 | chr9:17998171-17998172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144834654 | chr9:17998195-17998196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs60097187 | chr9:17998210-17998211 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs559084577 | chr9:17998211-17998212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs12378851 | chr9:17998231-17998232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545774000 | chr9:17998252-17998253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 22183965 | CNVD |
Ovarian cancer | 19835627 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:17988200-18004400 | Weak transcription | Aorta | Aorta |
2 | chr9:17990600-17998000 | Enhancers | Hela-S3 | cervix |
3 | chr9:17995200-18003400 | Weak transcription | Duodenum Mucosa | Duodenum |
4 | chr9:17995400-18002000 | Weak transcription | Duodenum Smooth Muscle | Duodenum |